MICHAEL A FULOP

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry BALTIMORE, MD NPI 1679589840

General Payments — all program years on this page

$3,880.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 209
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $345.12 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $345.1214

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,060.7466
2019 $929.0852
2020 $518.8224
2021 $572.4930
2022 $260.9114
2023 $192.969
2024 $345.1214

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078042580 Janssen Pharmaceuticals, Inc $28.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078042850 Janssen Pharmaceuticals, Inc $29.86 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101854630 E.R. Squibb & Sons, L.L.C. $21.03 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103760544 ABBVIE INC. $21.05 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103760546 ABBVIE INC. $15.41 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137563220 Almatica Pharma LLC $28.46 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143227118 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143227122 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.66 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143227126 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.43 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143227129 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.60 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143227133 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.07 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150827783 Neurocrine Biosciences, Inc. $29.12 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150853039 Neurocrine Biosciences, Inc. $21.52 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570727 Teva Pharmaceuticals USA, Inc. $21.77 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.